Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer-Reference-Cited by-同舟云学术

Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer

Published:1991 Issue:5 Volume:27 Page:367-372
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Haynes Benjamin P.,Jarman Michael,Dowsett Mitchell,Mehta Anshumala,L�nning Per E.,Griggs Leslie J.,Jones Alison,Powles Trevor,Stein Rob,Coombes R. Charles

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00688859.pdf

Reference34 articles.

1. Arnold K, Gerber N (1970) The rate of decline of diphenylhydantoin in human plasma. Clin Pharmacol Ther 11: 121?134

2. Bochner F, Graham GG, Elliot Cham B, Imhoff DM, Haavisto TM (1981) Salicylate metabolite kinetics after several salicylates. Clin Pharmacol Ther 30: 266?275

3. Damanhouri Z (1987) Drug interactions with the anticancer drug aminalutethinide and related compounds. PhD Thesis, University of Wales

4. Damanhouri Z, Herbert SA, Nicholls PJ (1987) Aminoglutethimide as an inducer of oxidative drug metabolism in the rat. Pharmacol Ther 33: 145?152

5. Dexter RN, Fishman LM, Ney RL, Liddle GW (1967) Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action. J Clin Endocrinol 27: 473?480

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of letrozole on spermogram parameters and hormonal profile in infertile men: A clinical trial study;Endocrine Regulations;2019-10-01

2. Enantiomeric resolution and simulation studies of four enantiomers of 5-bromo-3-ethyl-3-(4-nitrophenyl)-piperidine-2,6-dione on a Chiralpak IA column;RSC Advances;2016

3. The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum;Annals of Oncology;2011-03

4. The Cancer Research UK experience of pre-clinical toxicology studies to support early clinical trials with novel cancer therapies;European Journal of Cancer;2004-04

5. Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK;British Journal of Cancer;2003-07-29